-Bridge the Gap Bring the Change

Tag Indian Patent Office

Debunking Pharma’s Cant Against the Novartis Judgment: Myth and Fact

Professor Brook K. Baker, Senior Policy Analyst Health GAP April 2, 2013, IP Novartis, its fellow Big Pharma multinationals, Chambers of Commerce, and PhRMA have all roundly denounced India’s Supreme Court’s decision invalidating Novartis’ patent application for Glivec (Gleevec in… Continue Reading →

#India- SC rejects Novartis’s patent plea for cancer drug Glivec #goodnews

Vidya Krishnan , livemint Court says Glivec does not meet any standard of ‘novelty or inventiveness’ to qualify for a patent First Published: Mon, Apr 01 2013. Shares of Novartis India fell as much as 7% after the Supreme Court judgement. The… Continue Reading →

Pharma vs India: a case of life or death for the world’s poor #Health #drugs

WEB EXCLUSIVE, New International  Oct , 2012 Cases being heard in Indian courts could ‘open the floodgates’ for pharmaceutical companies to challenge generic drug production and keep prices ridiculously high, explains Nick Harvey. It’s a worrying time for the poor and… Continue Reading →

© 2024 Kractivism — Powered by WordPress

Theme by Anders NorenUp ↑